<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03322046</url>
  </required_header>
  <id_info>
    <org_study_id>CA-13-002</org_study_id>
    <nct_id>NCT03322046</nct_id>
  </id_info>
  <brief_title>Heartmatters Challenge - First Responders</brief_title>
  <acronym>HMC-FR</acronym>
  <official_title>Heartmatters Challenge - First Responders</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Boston Heart Diagnostics</agency>
      <agency_class>Industry</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Heart Fit for Duty, LLC</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Boston Heart Diagnostics</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      The purpose of this protocol is to observe whether providing the first responder population
      with a multi-tiered therapeutic lifestyle modification program, including regular blood
      testing, diet and telephonic lifestyle coaching, daily food journaling using web-based tools
      and smartphone apps can lead to positive changes in behavior, resulting in improvements in
      blood based markers of risk of cardiovascular disease (CVD) as well as improvements in weight
      and waist circumference.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      A cluster randomization of first responder communities in the metro Boston and metro Phoenix
      areas was performed. First responders attended a one hour lecture on the specific risks of
      CVD in that population and then qualified intervention candidates were enrolled into a
      lifestyle program, consisting of telephone-based coaching sessions with a registered
      dietitian and an online/app based food journaling program. Both groups had blood test draws
      at baseline, 3, 6 and 12 months. The intervention group met with the team practitioner to
      review results and progress after each blood draw. The test panel comprised blood-based
      markers of CVD risk associated with lipid metabolism, metabolics, inflammation and basic
      liver and kidney function.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date type="Actual">October 8, 2013</start_date>
  <completion_date type="Actual">January 8, 2015</completion_date>
  <primary_completion_date type="Actual">November 20, 2014</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Weight loss</measure>
    <time_frame>12 months</time_frame>
    <description>Change in weight from baseline measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Reduction in waist circumference</measure>
    <time_frame>12 months</time_frame>
    <description>Change in waist circumference from baseline measurement</description>
  </primary_outcome>
  <primary_outcome>
    <measure>Increase in large HDL subparticles</measure>
    <time_frame>12 months</time_frame>
    <description>Change in concentration of large HDL particles measured by 2Dimensional gel electrophoresis</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Improvements in blood based markers of CVD risk</measure>
    <time_frame>12 months</time_frame>
    <description>Markers involved in lipid metabolism, inflammation and metabolics</description>
  </secondary_outcome>
  <number_of_groups>2</number_of_groups>
  <enrollment type="Actual">185</enrollment>
  <condition>Cardiovascular Diseases</condition>
  <arm_group>
    <arm_group_label>Therapeutic Lifestyle Change (TLC) Intervention Group</arm_group_label>
    <description>TLC group received CVD risk lecture, enrolled in lifestyle program, received follow-up visits from team practitioner after each blood draw, access to food journaling portal for 12 month period, telephonic coaching</description>
  </arm_group>
  <arm_group>
    <arm_group_label>Control Group</arm_group_label>
    <description>Control group received CVD risk lecture, then baseline, 3, 6, 12 month blood draws and 3 day food journals prior to each blood draw.</description>
  </arm_group>
  <intervention>
    <intervention_type>Behavioral</intervention_type>
    <intervention_name>Lifestyle Program</intervention_name>
    <description>4 elements: 1) Laboratory test results with diagnostic report describing results, 2) Lifestyle plan generated in online portal with personalized nutritional information based on combination of laboratory results and personal preferences, 3) online or smartphone food journaling application, 4) telephone based lifestyle coaching with Registered Dietitian.</description>
    <arm_group_label>Therapeutic Lifestyle Change (TLC) Intervention Group</arm_group_label>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Serum, plasma
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        First responders: fire fighters, police officers, EMT personnel
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          1. Low apolipoprotein A-1 (apoA-1) levels in the very large alpha-1 HDL particle (&lt;20
             mg/dL for men, &lt;30 mg/dL for women) OR increased waist size (at least 40 inches for
             men or 35 inches for women).

          2. Internet access

          3. 14 day food log completed prior to initiating the study intervention (or 3-day food
             log for the control group).

        Exclusion Criteria:

          1. No insulin-requiring diabetes

          2. No pregnancy or plans to get pregnant in next 12 months

          3. Unable or unwilling to follow protocol

          4. Unavailable for duration of study

          5. Planning to change jobs during study term
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>65 Years</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Michael Dansinger, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Boston Heart Diagnostics</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Boston Heart Diagnostics</name>
      <address>
        <city>Framingham</city>
        <state>Massachusetts</state>
        <zip>01702</zip>
        <country>United States</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>United States</country>
  </location_countries>
  <results_reference>
    <citation>Asztalos BF, Batista M, Horvath KV, Cox CE, Dallal GE, Morse JS, Brown GB, Schaefer EJ. Change in alpha1 HDL concentration predicts progression in coronary artery stenosis. Arterioscler Thromb Vasc Biol. 2003 May 1;23(5):847-52. Epub 2003 Mar 13.</citation>
    <PMID>12637338</PMID>
  </results_reference>
  <results_reference>
    <citation>Asztalos BF, Cupples LA, Demissie S, Horvath KV, Cox CE, Batista MC, Schaefer EJ. High-density lipoprotein subpopulation profile and coronary heart disease prevalence in male participants of the Framingham Offspring Study. Arterioscler Thromb Vasc Biol. 2004 Nov;24(11):2181-7. Epub 2004 Sep 23.</citation>
    <PMID>15388521</PMID>
  </results_reference>
  <results_reference>
    <citation>Kales SN, Soteriades ES, Christophi CA, Christiani DC. Emergency duties and deaths from heart disease among firefighters in the United States. N Engl J Med. 2007 Mar 22;356(12):1207-15.</citation>
    <PMID>17377158</PMID>
  </results_reference>
  <results_reference>
    <citation>Kales SN, Tsismenakis AJ, Zhang C, Soteriades ES. Blood pressure in firefighters, police officers, and other emergency responders. Am J Hypertens. 2009 Jan;22(1):11-20. doi: 10.1038/ajh.2008.296. Epub 2008 Oct 16. Review.</citation>
    <PMID>18927545</PMID>
  </results_reference>
  <results_reference>
    <citation>Poston WS, Jitnarin N, Haddock CK, Jahnke SA, Tuley BC. The impact of surveillance on weight change and predictors of change in a population-based firefighter cohort. J Occup Environ Med. 2012 Aug;54(8):961-8. doi: 10.1097/JOM.0b013e31825296e0.</citation>
    <PMID>22772954</PMID>
  </results_reference>
  <results_reference>
    <citation>Schaefer EJ, Santos RD, Asztalos BF. Marked HDL deficiency and premature coronary heart disease. Curr Opin Lipidol. 2010 Aug;21(4):289-97. doi: 10.1097/MOL.0b013e32833c1ef6. Review.</citation>
    <PMID>20616715</PMID>
  </results_reference>
  <results_reference>
    <citation>Soteriades ES, Hauser R, Kawachi I, Liarokapis D, Christiani DC, Kales SN. Obesity and cardiovascular disease risk factors in firefighters: a prospective cohort study. Obes Res. 2005 Oct;13(10):1756-63.</citation>
    <PMID>16286523</PMID>
  </results_reference>
  <verification_date>October 2017</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>October 18, 2017</study_first_submitted>
  <study_first_submitted_qc>October 24, 2017</study_first_submitted_qc>
  <study_first_posted type="Actual">October 26, 2017</study_first_posted>
  <last_update_submitted>October 24, 2017</last_update_submitted>
  <last_update_submitted_qc>October 24, 2017</last_update_submitted_qc>
  <last_update_posted type="Actual">October 26, 2017</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Therapeutic Lifestyle Change</keyword>
  <keyword>Cardiovascular Disease</keyword>
  <keyword>First Responders</keyword>
  <keyword>Firefighters</keyword>
  <keyword>CVD</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Cardiovascular Diseases</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

